1155287-37-8

Basic information

• Product Name: [4-(3-Bromo-phenyl)-6-cyano-benzothiazol-2-yl]-carbamic Acid tert-butyl Ester
• Synonyms: [4-(3-Bromo-phenyl)-6-cyano-benzothiazol-2-yl]-carbamic Acid tert-butyl Ester
• CAS NO: 1155287-37-8
• Molecular Weight: 430.325
• Mol File: 1155287-37-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [4-(3-Bromo-phenyl)-6-cyano-benzothiazol-2-yl]-carbamic Acid tert-butyl Ester(CAS DataBase Reference)
• NIST Chemistry Reference: [4-(3-Bromo-phenyl)-6-cyano-benzothiazol-2-yl]-carbamic Acid tert-butyl Ester(1155287-37-8)
• EPA Substance Registry System: [4-(3-Bromo-phenyl)-6-cyano-benzothiazol-2-yl]-carbamic Acid tert-butyl Ester(1155287-37-8)

Safety Data

• Hazardous Substances Data: 1155287-37-8(Hazardous Substances Data)

Upstream product

• 1155287-19-6 (4-bromo-6-cyano-benzothiazol-2-yl)-carbamic Acid tert-butyl Ester 
• 89598-96-9 (3-bromophenyl)boronic acid 

Downstream Products

• 1155287-38-9 [4-(3-Bromo-phenyl)-6-formyl-benzothiazol-2-yl]-carbamic Acid tert-butyl Ester 

Relevant articles and documents

SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

The invention relates to substituted benzothiazoles, benzoxazoles—and their counterparts having pyridine and pyrimidine rings replacing the benzene ring—that are PDE4 inhibitors useful for treating stroke, myocardial infarct, and cardiovascular inflammatory conditions, to pharmaceutical compositions comprising these compounds, and to methods for the treatment of stroke, myocardial infarct, and cardiovascular inflammatory conditions in a mammal. The compounds have general formula I: in which A and B are carbocycles or heterocycles. A particular embodiment is